Censure of Fusen Pharma (1652) and 5 directors
SEHK, 4-Jan-2023
The firm was listed in mid-2018 after raising HK$397m. It spent most of 2019 siphoning off RMB258m in unapproved "advances" to a company half-owned by Cao Changcheng, the founder, Chairman and controlling shareholder of Fusen Pharma. The funds were (apparently) repaid by Christmas Day that year.

• Orgs
  • Fusen Pharmaceutical Company Limited
• People
  • Cao, Changcheng 曹長城
  • Chi, Yongsheng 遲永勝
  • Hou, Taisheng 侯太生
  • Meng, Qingfen 孟慶芬